Laveena Kamboj is currently a PhD Candidate specializing in Health Technology Assessment (HTA) in the Health Research Methodology program at Mcmaster University. Her PhD thesis focuses on public and patient engagement in the drug review process across HTA agencies. She currently has an MSc in Health Research Methodology from McMaster University and a BSc in Toxicology from the University of Toronto.
She is Associate Director, Market Access & Government Affairs with Eisai where she leads the development and implementation of strategies in support of drug reimbursement. This includes the development and conduct of health economic analyses and outcomes research studies. She was also a Research Associate with the Centre for Evaluation and Medicines (CEM), St. Joseph’s Hospital in Hamilton where she studied health care decision-makers understanding of the cost per quality adjusted life year.